even report result beat elev expect provid
plethora posit updat profit pharmaci pipelin view
import take-away call new patient addit significantli
pipelin doubl prior year view truli
game chang platform doubl patient demand enough interest
payer coverag commerci live pharmaci top
profit impress quarter topic expect hear lot
analyst day posit updat still low penetr rate increas
pt unchang ev/sal multipl revis revenu reiter
ow rate
strong third quarter sale profit report sale beat
consensu elev buysid expect strength
broad base ou well durabl vs consum also
stood profit quarter ep vs street
upsid came lower sg spend
guidanc compani rais guidanc remaind impli growth
lot move piec given intern momentum
underli patient demand still feel pretti conserv us
compani give guidanc said know consensu
feel good number simpli put manag confid outlook
busi number readili achiev upsid still avail
new call lot new data point call lot posit
updat first pharmaci push know exact histor figur
seemingli go better previou gener system ye cari
lower revenu per patient drastic improv patient access lower
need back offic support never get commerci penetr
penetr today victori view even headwind next
quarter compani continu grow certainli complain
hear analyst day month profit profil
compani go come focu think surpris upsid also
icgm pathway full display week new product strategi
work one new product target non-intens patient popul
price unknown manag believ payer begin cover eventu
defin strategi product fully-dispos glucos
record devic indic peopl two-year older exclus peopl
diabet suggest broader push healthcar diagnost
develop continu glucos monitor diabet manag
price close novemb
sale
assum net cash fulli dilut
debt total capit
piper jaffray seek busi compani cover research report result investor awar
firm may conflict interest could affect object report investor consid report
singl factor make invest decis report read conjunct import disclosur inform
includ attest regul analyst certif found page report follow site
page
sourc compani report piper jaffray co estim
page
good gener incom expens net incom tax incom analysi gross gener breakdown durabl
thousand except per share
good sold
current disclosur inform compani locat http //www piperjaffray com/researchdisclosur
